BioNTech SE ( ($BNTX) ) has shared an update. On April 4, 2025, BioNTech SE announced the invitation to its Annual General Meeting scheduled for ...
We recently published a list of 12 Best German Stocks to Buy According to Hedge Funds. In this article, we are going to take ...
Mitsubishi UFJ Asset Management Co. Ltd. reduced its stake in BioNTech SE (NASDAQ:BNTX – Free Report) by 20.0% in the 4th ...
BioNTech (NASDAQ:BNTX – Get Free Report) had its target price dropped by analysts at HC Wainwright from $150.00 to $145.00 in ...
In trading on Tuesday, shares of BioNTech SE (Symbol: BNTX) entered into oversold territory, hitting an RSI reading of 29.3, after changing hands as low as $87.605 per share. By comparison ...
Truist Financial analyst Asthika Goonewardene maintained a Buy rating on BioNTech SE (BNTX – Research Report) today. The company’s shares ...
Explore more
US biotech Novavax (Nasdaq: NVAX) is still waiting on a decision from the Food and Drug Administration over full approval of its protein-based COVID-19 vaccine, despite the agency having set an April ...
The pharma and biotech sector has been under pressure since Donald Trump returned to the White House earlier this year.
H.C. Wainwright lowered the firm’s price target on BioNTech (BNTX) to $145 from $150 and keeps a Buy rating on the shares. The firm says ...
Among the largest underlying components of FNDF, in trading today Medtronic PLC (Symbol: MDT) is up about 1.3%, BioNTech SE (Symbol: BNTX) is down about 6.9%, and Ferguson Enterprises Inc (Symbol ...
The health agency’s top immunization official announced the move Monday in protest, citing Secretary Kennedy’s ...
Investing.com -- Moderna (NASDAQ: MRNA) shares dropped 13% pre-open on Monday as investors reacted to the weekend news that the U.S. Food and Drug Administration’s (FDA) top vaccine official, Dr.